These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
Delaware
|
20-3842867
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
400-1818 Cornwall Avenue,
Vancouver, British Columbia
|
V6J 1C7
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
þ
|
Accelerated filer
|
|
o
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
|
o
|
|
|
|
Page
|
|
|
|
|
|
|
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
|
|
|
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
|
|
|
November 3,
2013 |
|
February 3,
2013 |
||||
|
|
(Unaudited)
|
|
|
||||
|
|
(Amounts in thousands, except per share amounts)
|
||||||
ASSETS
|
||||||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
600,745
|
|
|
$
|
590,179
|
|
Accounts receivable
|
|
12,105
|
|
|
6,351
|
|
||
Inventories
|
|
206,154
|
|
|
155,222
|
|
||
Prepaid expenses and other current assets
|
|
61,587
|
|
|
35,301
|
|
||
|
|
880,591
|
|
|
787,053
|
|
||
Property and equipment, net
|
|
243,626
|
|
|
214,639
|
|
||
Goodwill and intangible assets, net
|
|
28,991
|
|
|
30,201
|
|
||
Deferred income taxes
|
|
16,103
|
|
|
15,033
|
|
||
Other non-current assets
|
|
5,243
|
|
|
4,152
|
|
||
|
|
$
|
1,174,554
|
|
|
$
|
1,051,078
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable
|
|
$
|
4,783
|
|
|
$
|
1,045
|
|
Accrued liabilities
|
|
38,221
|
|
|
30,032
|
|
||
Accrued compensation and related expenses
|
|
26,829
|
|
|
27,530
|
|
||
Income taxes payable
|
|
991
|
|
|
39,637
|
|
||
Unredeemed gift card liability
|
|
23,790
|
|
|
35,113
|
|
||
|
|
94,614
|
|
|
133,357
|
|
||
Non-current liabilities
|
|
37,180
|
|
|
30,422
|
|
||
|
|
131,794
|
|
|
163,779
|
|
||
Stockholders’ equity
|
|
|
|
|
||||
Undesignated preferred stock, $0.01 par value, 5,000 shares authorized, none issued and outstanding
|
|
—
|
|
|
—
|
|
||
Exchangeable stock, no par value, 60,000 shares authorized, issued and outstanding 29,983 and 32,065
|
|
—
|
|
|
—
|
|
||
Special voting stock, $0.000005 par value, 60,000 shares authorized, issued and outstanding 29,983 and 32,065
|
|
—
|
|
|
—
|
|
||
Common stock, $0.005 par value, 400,000 shares authorized, issued and outstanding 115,223 and 112,371
|
|
576
|
|
|
562
|
|
||
Additional paid-in capital
|
|
242,465
|
|
|
221,372
|
|
||
Retained earnings
|
|
814,130
|
|
|
644,275
|
|
||
Accumulated other comprehensive (loss) income
|
|
(14,411
|
)
|
|
21,090
|
|
||
|
|
1,042,760
|
|
|
887,299
|
|
||
|
|
$
|
1,174,554
|
|
|
$
|
1,051,078
|
|
|
|
Thirteen Weeks Ended November 3, 2013
|
|
Thirteen Weeks Ended
October 28, 2012 |
|
Thirty-Nine Weeks Ended November 3, 2013
|
|
Thirty-Nine Weeks Ended October 28, 2012
|
||||||||
|
|
(Unaudited)
|
||||||||||||||
|
|
(Amounts in thousands, except per share amounts)
|
||||||||||||||
Net revenue
|
|
$
|
379,900
|
|
|
$
|
316,537
|
|
|
$
|
1,070,195
|
|
|
$
|
884,869
|
|
Cost of goods sold
|
|
175,294
|
|
|
141,237
|
|
|
508,909
|
|
|
396,550
|
|
||||
Gross profit
|
|
204,606
|
|
|
175,300
|
|
|
561,286
|
|
|
488,319
|
|
||||
Selling, general and administrative expenses
|
|
112,270
|
|
|
94,689
|
|
|
324,075
|
|
|
264,455
|
|
||||
Income from operations
|
|
92,336
|
|
|
80,611
|
|
|
237,211
|
|
|
223,864
|
|
||||
Other income (expense), net
|
|
1,453
|
|
|
1,424
|
|
|
4,249
|
|
|
3,500
|
|
||||
Income before provision for income taxes
|
|
93,789
|
|
|
82,035
|
|
|
241,460
|
|
|
227,364
|
|
||||
Provision for income taxes
|
|
27,678
|
|
|
24,655
|
|
|
71,605
|
|
|
65,308
|
|
||||
Net income
|
|
66,111
|
|
|
57,380
|
|
|
169,855
|
|
|
162,056
|
|
||||
Net income attributable to non-controlling interest
|
|
—
|
|
|
64
|
|
|
—
|
|
|
875
|
|
||||
Net income attributable to lululemon athletica inc.
|
|
$
|
66,111
|
|
|
$
|
57,316
|
|
|
$
|
169,855
|
|
|
$
|
161,181
|
|
Basic earnings per share
|
|
$
|
0.46
|
|
|
$
|
0.40
|
|
|
$
|
1.17
|
|
|
$
|
1.12
|
|
Diluted earnings per share
|
|
$
|
0.45
|
|
|
$
|
0.39
|
|
|
$
|
1.16
|
|
|
$
|
1.11
|
|
Basic weighted-average number of shares outstanding
|
|
145,120
|
|
|
144,057
|
|
|
144,806
|
|
|
143,903
|
|
||||
Diluted weighted-average number of shares outstanding
|
|
146,014
|
|
|
145,748
|
|
|
145,967
|
|
|
145,750
|
|
||||
Other comprehensive income:
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment
|
|
(9,153
|
)
|
|
2,642
|
|
|
(35,501
|
)
|
|
(381
|
)
|
||||
Comprehensive income
|
|
$
|
56,958
|
|
|
$
|
59,958
|
|
|
$
|
134,354
|
|
|
$
|
160,800
|
|
|
|
Exchangeable
Stock
|
|
Special Voting
Stock
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
Shares
|
|
Par
Value
|
|
Shares
|
|
Par
Value
|
|
Shares
|
|
Par
Value
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Total
|
|||||||||||||||||
|
|
(Unaudited)
(Amounts in thousands) |
|||||||||||||||||||||||||||||||||||
Balance at February 3, 2013
|
|
32,065
|
|
|
$
|
—
|
|
|
32,065
|
|
|
$
|
—
|
|
|
112,371
|
|
|
$
|
562
|
|
|
$
|
221,372
|
|
|
$
|
644,275
|
|
|
$
|
21,090
|
|
|
$
|
887,299
|
|
Net income attributable to lululemon athletica inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
169,855
|
|
|
|
|
169,855
|
|
|||||||||||||||
Foreign currency translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35,501
|
)
|
|
(35,501
|
)
|
|||||||||||||||
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,453
|
|
|
|
|
|
|
12,453
|
|
|||||||||||||||
Excess tax benefit from stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,453
|
|
|
|
|
|
|
6,453
|
|
|||||||||||||||
Common stock issued upon exchange of exchangeable shares
|
|
(2,082
|
)
|
|
—
|
|
|
(2,082
|
)
|
|
—
|
|
|
2,082
|
|
|
10
|
|
|
(10
|
)
|
|
|
|
|
|
—
|
|
|||||||||
Restricted share issuance
|
|
|
|
|
|
|
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
—
|
|
|||||||||||||
Stock options exercised
|
|
|
|
|
|
|
|
|
|
647
|
|
|
3
|
|
|
7,475
|
|
|
|
|
|
|
7,478
|
|
|||||||||||||
Common stock issued upon settlement of performance-based restricted stock units
|
|
|
|
|
|
|
|
|
|
191
|
|
|
1
|
|
|
(1
|
)
|
|
|
|
|
|
—
|
|
|||||||||||||
Shares withheld related to net share settlement of performance-based restricted stock units
|
|
|
|
|
|
|
|
|
|
(83
|
)
|
|
—
|
|
|
(5,277
|
)
|
|
|
|
|
|
(5,277
|
)
|
|||||||||||||
Balance at November 3, 2013
|
|
29,983
|
|
|
$
|
—
|
|
|
29,983
|
|
|
$
|
—
|
|
|
115,223
|
|
|
$
|
576
|
|
|
$
|
242,465
|
|
|
$
|
814,130
|
|
|
$
|
(14,411
|
)
|
|
$
|
1,042,760
|
|
|
|
Thirty-Nine Weeks Ended
November 3, 2013 |
|
Thirty-Nine Weeks Ended
October 28, 2012 |
||||
|
|
(Unaudited)
(Amounts in thousands)
|
||||||
Cash flows from operating activities
|
|
|
|
|
||||
Net income
|
|
$
|
169,855
|
|
|
$
|
162,056
|
|
Items not affecting cash
|
|
|
|
|
||||
Provision for inventories
|
|
18,316
|
|
|
724
|
|
||
Depreciation and amortization
|
|
36,723
|
|
|
30,962
|
|
||
Stock-based compensation
|
|
12,453
|
|
|
11,828
|
|
||
Excess tax benefits from stock-based compensation
|
|
(6,453
|
)
|
|
(7,172
|
)
|
||
Other, including net changes in other non-cash balances
|
|
|
|
|
||||
Prepaid tax installments
|
|
(12,124
|
)
|
|
(9,315
|
)
|
||
Other prepaid expenses and other current assets
|
|
(14,645
|
)
|
|
(6,965
|
)
|
||
Inventories
|
|
(72,052
|
)
|
|
(61,262
|
)
|
||
Accounts payable
|
|
3,728
|
|
|
(7,958
|
)
|
||
Accrued liabilities
|
|
7,230
|
|
|
11,048
|
|
||
Sales tax collected
|
|
270
|
|
|
(7,573
|
)
|
||
Income taxes payable
|
|
(40,272
|
)
|
|
(1,858
|
)
|
||
Accrued compensation and related expenses
|
|
(1,474
|
)
|
|
(663
|
)
|
||
Other non-cash balances
|
|
(6,749
|
)
|
|
(612
|
)
|
||
Net cash provided by operating activities
|
|
94,806
|
|
|
113,240
|
|
||
Cash flows from investing activities
|
|
|
|
|
||||
Purchase of property and equipment
|
|
(71,945
|
)
|
|
(72,041
|
)
|
||
Net cash used in investing activities
|
|
(71,945
|
)
|
|
(72,041
|
)
|
||
Cash flows from financing activities
|
|
|
|
|
||||
Proceeds from exercise of stock options
|
|
7,478
|
|
|
6,978
|
|
||
Excess tax benefits from stock-based compensation
|
|
6,453
|
|
|
7,172
|
|
||
Purchase of non-controlling interest
|
|
—
|
|
|
(26,013
|
)
|
||
Taxes paid related to net share settlement of equity awards
|
|
(5,277
|
)
|
|
—
|
|
||
Net cash provided by (used in) financing activities
|
|
8,654
|
|
|
(11,863
|
)
|
||
Effect of exchange rate changes on cash
|
|
(20,949
|
)
|
|
650
|
|
||
Increase in cash and cash equivalents
|
|
10,566
|
|
|
29,986
|
|
||
Cash and cash equivalents, beginning of period
|
|
$
|
590,179
|
|
|
$
|
409,437
|
|
Cash and cash equivalents, end of period
|
|
$
|
600,745
|
|
|
$
|
439,423
|
|
|
|
Number of
Stock
Options
|
|
Weighted-
Average
Exercise
Price
|
|
Number of
Performance-Based Restricted Stock
Units
|
|
Weighted-
Average
Grant
Fair Value
|
|
Number of
Restricted
Shares
|
|
Weighted-
Average
Grant
Fair Value
|
|||||||||
Balance at February 3, 2013
|
|
1,377
|
|
|
$
|
19.51
|
|
|
491
|
|
|
$
|
45.47
|
|
|
16
|
|
|
$
|
63.97
|
|
Granted
|
|
97
|
|
|
66.34
|
|
|
267
|
|
|
52.61
|
|
|
17
|
|
|
64.30
|
|
|||
Exercised
|
|
647
|
|
|
11.56
|
|
|
191
|
|
|
20.74
|
|
|
16
|
|
|
63.97
|
|
|||
Forfeited
|
|
52
|
|
|
24.83
|
|
|
24
|
|
|
60.98
|
|
|
2
|
|
|
64.30
|
|
|||
Balance at November 3, 2013
|
|
775
|
|
|
$
|
31.67
|
|
|
543
|
|
|
$
|
57.01
|
|
|
15
|
|
|
$
|
64.30
|
|
Exercisable at November 3, 2013
|
|
364
|
|
|
$
|
16.51
|
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
|
Thirteen Weeks Ended November 3, 2013
|
|
Thirteen Weeks Ended October 28, 2012
|
|
Thirty-Nine Weeks Ended November 3, 2013
|
|
Thirty-Nine Weeks Ended October 28, 2012
|
||||||||
Net income attributable to lululemon athletica inc.
|
|
$
|
66,111
|
|
|
$
|
57,316
|
|
|
$
|
169,855
|
|
|
$
|
161,181
|
|
Basic weighted-average number of shares outstanding
|
|
145,120
|
|
|
144,057
|
|
|
144,806
|
|
|
143,903
|
|
||||
Effect of stock options assume exercised
|
|
894
|
|
|
1,691
|
|
|
1,161
|
|
|
1,847
|
|
||||
Diluted weighted-average number of shares outstanding
|
|
146,014
|
|
|
145,748
|
|
|
145,967
|
|
|
145,750
|
|
||||
Basic earnings per share
|
|
$
|
0.46
|
|
|
$
|
0.40
|
|
|
$
|
1.17
|
|
|
$
|
1.12
|
|
Diluted earnings per share
|
|
$
|
0.45
|
|
|
$
|
0.39
|
|
|
$
|
1.16
|
|
|
$
|
1.11
|
|
|
|
November 3,
2013 |
|
February 3,
2013 |
||||
Finished goods
|
|
$
|
232,270
|
|
|
$
|
163,008
|
|
Raw materials
|
|
568
|
|
|
583
|
|
||
Provision to reduce inventory to market value
|
|
(26,684
|
)
|
|
(8,369
|
)
|
||
|
|
$
|
206,154
|
|
|
$
|
155,222
|
|
|
|
November 3,
2013 |
|
February 3,
2013 |
||||
Prepaid expenses and other current assets:
|
|
|
|
|
||||
Prepaid tax installments
|
|
$
|
40,398
|
|
|
$
|
21,821
|
|
Prepaid expenses
|
|
21,189
|
|
|
13,480
|
|
||
|
|
$
|
61,587
|
|
|
$
|
35,301
|
|
Property and equipment:
|
|
|
|
|
||||
Land
|
|
$
|
69,773
|
|
|
$
|
72,679
|
|
Buildings
|
|
10,554
|
|
|
10,969
|
|
||
Leasehold improvements
|
|
140,927
|
|
|
109,233
|
|
||
Furniture and fixtures
|
|
38,872
|
|
|
30,907
|
|
||
Computer hardware and software
|
|
96,687
|
|
|
81,099
|
|
||
Equipment and vehicles
|
|
1,487
|
|
|
1,486
|
|
||
Accumulated amortization and depreciation
|
|
(114,674
|
)
|
|
(91,734
|
)
|
||
|
|
$
|
243,626
|
|
|
$
|
214,639
|
|
Goodwill and intangible assets:
|
|
|
|
|
||||
Goodwill
|
|
$
|
23,609
|
|
|
$
|
23,609
|
|
Changes in foreign currency exchange rates
|
|
879
|
|
|
2,451
|
|
||
|
|
24,488
|
|
|
26,060
|
|
||
Reacquired franchise rights
|
|
10,630
|
|
|
10,630
|
|
||
Accumulated amortization
|
|
(8,490
|
)
|
|
(8,076
|
)
|
||
Changes in foreign currency exchange rates
|
|
2,363
|
|
|
1,587
|
|
||
|
|
4,503
|
|
|
4,141
|
|
||
|
|
$
|
28,991
|
|
|
$
|
30,201
|
|
Accrued liabilities:
|
|
|
|
|
||||
Inventory purchases
|
|
$
|
12,837
|
|
|
$
|
7,633
|
|
Sales tax collected
|
|
8,909
|
|
|
8,501
|
|
||
Accrued rent
|
|
5,093
|
|
|
5,688
|
|
||
Other
|
|
11,382
|
|
|
8,210
|
|
||
|
|
$
|
38,221
|
|
|
$
|
30,032
|
|
Non-current liabilities:
|
|
|
|
|
||||
Deferred lease liability
|
|
$
|
17,921
|
|
|
$
|
16,785
|
|
Tenant inducements
|
|
19,259
|
|
|
13,637
|
|
||
|
|
$
|
37,180
|
|
|
$
|
30,422
|
|
|
|
Thirteen Weeks Ended
November 3, 2013 |
|
Thirteen Weeks Ended
October 28, 2012 |
|
Thirty-Nine Weeks Ended
November 3, 2013 |
|
Thirty-Nine Weeks Ended
October 28, 2012 |
||||||||
Net revenue:
|
|
|
|
|
|
|
|
|
||||||||
Corporate-owned stores
|
|
$
|
290,666
|
|
|
$
|
252,046
|
|
|
$
|
833,792
|
|
|
$
|
712,149
|
|
Direct to consumer
|
|
61,954
|
|
|
45,122
|
|
|
165,304
|
|
|
118,991
|
|
||||
Other
|
|
27,280
|
|
|
19,369
|
|
|
71,099
|
|
|
53,729
|
|
||||
|
|
$
|
379,900
|
|
|
$
|
316,537
|
|
|
$
|
1,070,195
|
|
|
$
|
884,869
|
|
Income from operations before general corporate expense:
|
|
|
|
|
|
|
|
|
||||||||
Corporate-owned stores
|
|
$
|
89,676
|
|
|
$
|
84,438
|
|
|
$
|
244,915
|
|
|
$
|
242,045
|
|
Direct to consumer
|
|
27,980
|
|
|
19,167
|
|
|
68,999
|
|
|
51,644
|
|
||||
Other
|
|
4,597
|
|
|
4,278
|
|
|
12,755
|
|
|
11,597
|
|
||||
|
|
122,253
|
|
|
107,883
|
|
|
326,669
|
|
|
305,286
|
|
||||
General corporate expense
|
|
29,917
|
|
|
27,272
|
|
|
89,458
|
|
|
81,422
|
|
||||
Income from operations
|
|
92,336
|
|
|
80,611
|
|
|
237,211
|
|
|
223,864
|
|
||||
Other income (expense), net
|
|
1,453
|
|
|
1,424
|
|
|
4,249
|
|
|
3,500
|
|
||||
Income before provision for income taxes
|
|
$
|
93,789
|
|
|
$
|
82,035
|
|
|
$
|
241,460
|
|
|
$
|
227,364
|
|
Capital expenditures:
|
|
|
|
|
|
|
|
|
||||||||
Corporate-owned stores
|
|
$
|
17,576
|
|
|
$
|
23,103
|
|
|
$
|
44,016
|
|
|
$
|
52,573
|
|
Direct to consumer
|
|
1,051
|
|
|
1,733
|
|
|
3,814
|
|
|
2,564
|
|
||||
Corporate
|
|
9,305
|
|
|
8,159
|
|
|
24,115
|
|
|
16,904
|
|
||||
|
|
$
|
27,932
|
|
|
$
|
32,995
|
|
|
$
|
71,945
|
|
|
$
|
72,041
|
|
Depreciation:
|
|
|
|
|
|
|
|
|
||||||||
Corporate-owned stores
|
|
$
|
7,847
|
|
|
$
|
7,826
|
|
|
$
|
22,850
|
|
|
$
|
20,957
|
|
Direct to consumer
|
|
1,190
|
|
|
639
|
|
|
3,303
|
|
|
2,296
|
|
||||
Corporate
|
|
3,879
|
|
|
3,036
|
|
|
10,570
|
|
|
7,709
|
|
||||
|
|
$
|
12,916
|
|
|
$
|
11,501
|
|
|
$
|
36,723
|
|
|
$
|
30,962
|
|
|
|
Thirteen Weeks Ended November 3, 2013 and October 28, 2012
|
||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||
Net revenue
|
|
$
|
379,900
|
|
|
$
|
316,537
|
|
|
100.0
|
|
100.0
|
Cost of goods sold
|
|
175,294
|
|
|
141,237
|
|
|
46.1
|
|
44.6
|
||
Gross profit
|
|
204,606
|
|
|
175,300
|
|
|
53.9
|
|
55.4
|
||
Selling, general and administrative expenses
|
|
112,270
|
|
|
94,689
|
|
|
29.6
|
|
29.9
|
||
Income from operations
|
|
92,336
|
|
|
80,611
|
|
|
24.3
|
|
25.5
|
||
Other income (expense), net
|
|
1,453
|
|
|
1,424
|
|
|
0.4
|
|
0.4
|
||
Income before provision for income taxes
|
|
93,789
|
|
|
82,035
|
|
|
24.7
|
|
25.9
|
||
Provision for income taxes
|
|
27,678
|
|
|
24,655
|
|
|
7.3
|
|
7.8
|
||
Net income
|
|
66,111
|
|
|
57,380
|
|
|
17.4
|
|
18.1
|
||
Net income attributable to non-controlling interest
|
|
—
|
|
|
64
|
|
|
—
|
|
—
|
||
Net income attributable to lululemon athletica inc.
|
|
$
|
66,111
|
|
|
$
|
57,316
|
|
|
17.4
|
|
18.1
|
|
|
Thirteen Weeks Ended November 3, 2013 and October 28, 2012
|
||||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||||
Corporate-owned stores
|
|
$
|
290,666
|
|
|
$
|
252,046
|
|
|
76.5
|
|
|
79.6
|
|
Direct to consumer
|
|
61,954
|
|
|
45,122
|
|
|
16.3
|
|
|
14.3
|
|
||
Other
|
|
27,280
|
|
|
19,369
|
|
|
7.2
|
|
|
6.1
|
|
||
Net revenue
|
|
$
|
379,900
|
|
|
$
|
316,537
|
|
|
100.0
|
|
|
100.0
|
|
•
|
Comparable store sales
increase
of
2%
in the
third
quarter of fiscal
2013
resulted in a
$5.3 million
increase
to net revenue, including the effect of foreign currency fluctuations. Excluding the effect of foreign currency fluctuations, comparable store sales would have
increased
5%
, or
$10.6 million
, in the
third
quarter of fiscal
2013
; and
|
•
|
Net revenue from corporate-owned stores we opened subsequent to
October 28, 2012
, and therefore not included in the comparable store sales growth, contributed
$33.3 million
of the
increase
. Net new store openings since the
third
quarter of fiscal
2012
included
39
stores in the United States,
three
stores in Canada,
three
stores in Australia and
one
store in New Zealand.
|
•
|
an
increase
in employee costs of
$6.1 million
as we experienced natural growth in labor hours associated with new and existing corporate-owned stores, outlets, showrooms and other, as well as an increase in wages as we invested in our employees;
|
•
|
an
increase
in variable store costs of
$2.0 million
as a result of increased sales volume from new and existing corporate-owned stores, outlets, showrooms and other;
|
•
|
an
increase
in head office employee costs of
$3.3 million
from increased head count incurred in order to position us for long-term growth;
|
•
|
an
increase
in other head office costs of
$2.9 million
as a result of the overall growth of our business and investment in strategic initiatives and projects;
|
•
|
an
increase
in variable costs such as distribution costs, credit card fees and packaging related to our direct to consumer segment of
$0.9 million
as a result of increased sales volume;
|
•
|
an
increase
in administrative costs related to our direct to consumer segment of
$1.0 million
associated with the growth in this channel and increased head count to support it; and
|
•
|
an
increase
in other costs, including occupancy costs and depreciation not included in cost of goods sold, of
$1.4 million
as a result of the expansion of our business.
|
|
|
Thirteen Weeks Ended November 3, 2013 and October 28, 2012
|
||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||
Corporate-owned stores
|
|
$
|
89,676
|
|
|
$
|
84,438
|
|
|
30.9
|
|
33.5
|
Direct to consumer
|
|
27,980
|
|
|
19,167
|
|
|
45.2
|
|
42.5
|
||
Other
|
|
4,597
|
|
|
4,278
|
|
|
16.9
|
|
22.1
|
||
Income from operations before general corporate expense
|
|
122,253
|
|
|
107,883
|
|
|
|
|
|
||
General corporate expense
|
|
29,917
|
|
|
27,272
|
|
|
|
|
|
||
Income from operations
|
|
$
|
92,336
|
|
|
$
|
80,611
|
|
|
|
|
|
|
|
Thirty-Nine Week November 3, 2013 and October 28, 2012
|
||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||
Net revenue
|
|
$
|
1,070,195
|
|
|
$
|
884,869
|
|
|
100.0
|
|
100.0
|
Cost of goods sold
|
|
$
|
508,909
|
|
|
$
|
396,550
|
|
|
47.6
|
|
44.8
|
Gross profit
|
|
$
|
561,286
|
|
|
$
|
488,319
|
|
|
52.4
|
|
55.2
|
Selling, general and administrative expenses
|
|
$
|
324,075
|
|
|
$
|
264,455
|
|
|
30.2
|
|
29.9
|
Income from operations
|
|
$
|
237,211
|
|
|
$
|
223,864
|
|
|
22.2
|
|
25.3
|
Other income (expense), net
|
|
$
|
4,249
|
|
|
$
|
3,500
|
|
|
0.4
|
|
0.4
|
Income before provision for income taxes
|
|
$
|
241,460
|
|
|
$
|
227,364
|
|
|
22.6
|
|
25.7
|
Provision for income taxes
|
|
$
|
71,605
|
|
|
$
|
65,308
|
|
|
6.7
|
|
7.4
|
Net income
|
|
$
|
169,855
|
|
|
$
|
162,056
|
|
|
15.9
|
|
18.3
|
Net income attributable to non-controlling interest
|
|
—
|
|
|
875
|
|
|
—
|
|
0.1
|
||
Net income attributable to lululemon athletica inc.
|
|
$
|
169,855
|
|
|
$
|
161,181
|
|
|
15.9
|
|
18.2
|
|
|
Thirty-Nine Week November 3, 2013 and October 28, 2012
|
||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||
Corporate-owned stores
|
|
$
|
833,792
|
|
|
$
|
712,149
|
|
|
77.9
|
|
80.5
|
Direct to consumer
|
|
165,304
|
|
|
118,991
|
|
|
15.5
|
|
13.4
|
||
Other
|
|
71,099
|
|
|
53,729
|
|
|
6.6
|
|
6.1
|
||
Net revenue
|
|
$
|
1,070,195
|
|
|
$
|
884,869
|
|
|
100.0
|
|
100.0
|
•
|
Comparable store sales
increase
of
5%
in the first
three quarters
of fiscal
2013
resulted in a
$35.1 million
increase
to net revenue, including the effect of foreign currency fluctuations. Excluding the effect of foreign currency fluctuations, comparable store sales
increased
7%
, or
$44.2 million
, in the first
three quarters
of fiscal
2013
; and
|
•
|
Net revenue from corporate-owned stores we opened subsequent to
October 28, 2012
, and therefore not included in the comparable store sales growth, contributed
$86.5 million
of the increase. Net new store openings since the
third
quarter of fiscal
2012
included
39
stores in the United States,
three
stores in Canada,
three
stores in Australia and
one
store in New Zealand.
|
•
|
a decrease in product margin of 170 basis points due to a lower sales mix of higher margin core items related to the pull-back of black luon pants, along with higher markdowns and an increase in provision for inventories charged to cost of sales; and
|
•
|
a non-recurring charge of 160 basis points related to the pull-back of black luon pants in the first quarter of fiscal 2013.
|
•
|
an
increase
in employee costs of
$21.1 million
as we experienced natural growth in labor hours associated with new and existing corporate-owned stores, showrooms, outlets and other, as well as an increase in wages as we invest in our employees;
|
•
|
an
increase
in variable store costs of
$6.0 million
as a result of increased sales volume from new and existing corporate-owned stores, outlets and other;
|
•
|
an
increase
in head office employee costs, including stock-based compensation expense and management incentive-based compensation, of
$10.5 million
incurred in order to position us for long-term growth;
|
•
|
an
increase
in other head office costs of
$11.3 million
as a result of the overall growth of our business and investment in strategic initiatives and projects;
|
•
|
an
increase
in administrative expenses related to our direct to consumer segment of
$4.9 million
associated with the growth in this channel;
|
•
|
an
increase
in variable costs such as distribution costs, credit card fees and packaging related to our direct to consumer segment of
$3.7 million
as a result of increased sales volume; and
|
•
|
an
increase
of
$2.1 million
in other costs, including occupancy costs and depreciation not included in cost of goods sold, as a result of the expansion of our business, which was partially offset by a $6.2 million foreign exchange gain in our Canadian operating entity.
|
|
|
Thirty-Nine Week November 3, 2013 and October 28, 2012
|
||||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
|
(Percentages)
|
||||||||
Corporate-owned stores
|
|
$
|
244,915
|
|
|
$
|
242,045
|
|
|
29.4
|
|
34.0
|
Direct to consumer
|
|
68,999
|
|
|
51,644
|
|
|
41.7
|
|
43.4
|
||
Other
|
|
12,755
|
|
|
11,597
|
|
|
17.9
|
|
21.6
|
||
Income from operations before general corporate expense
|
|
326,669
|
|
|
305,286
|
|
|
|
|
|
||
General corporate expense
|
|
89,458
|
|
|
81,422
|
|
|
|
|
|
||
Income from operations
|
|
$
|
237,211
|
|
|
$
|
223,864
|
|
|
|
|
|
|
|
Thirty-Nine Weeks Ended
November 3, 2013 |
|
Thirty-Nine Weeks Ended
October 28, 2012 |
||||
|
|
(In thousands)
|
||||||
Total cash provided by (used in):
|
|
|
|
|
||||
Operating activities
|
|
$
|
94,806
|
|
|
$
|
113,240
|
|
Investing activities
|
|
(71,945
|
)
|
|
(72,041
|
)
|
||
Financing activities
|
|
8,654
|
|
|
(11,863
|
)
|
||
Effect of exchange rate changes on cash
|
|
(20,949
|
)
|
|
650
|
|
||
Increase in cash and cash equivalents
|
|
$
|
10,566
|
|
|
$
|
29,986
|
|
|
|
November 3, 2013
|
|
February 3, 2013
|
||
United States
|
|
|
|
|
||
Alabama
|
|
1
|
|
|
1
|
|
Arizona
|
|
5
|
|
|
3
|
|
Arkansas
|
|
1
|
|
|
—
|
|
California
|
|
28
|
|
|
24
|
|
Colorado
|
|
3
|
|
|
3
|
|
Connecticut
|
|
3
|
|
|
3
|
|
District of Columbia
|
|
2
|
|
|
2
|
|
Florida
|
|
8
|
|
|
8
|
|
Georgia
|
|
3
|
|
|
3
|
|
Hawaii
|
|
1
|
|
|
1
|
|
Illinois
|
|
10
|
|
|
9
|
|
Indiana
|
|
1
|
|
|
1
|
|
Kansas
|
|
1
|
|
|
1
|
|
Louisiana
|
|
1
|
|
|
1
|
|
Maryland
|
|
4
|
|
|
3
|
|
Massachusetts
|
|
8
|
|
|
6
|
|
Michigan
|
|
3
|
|
|
2
|
|
Minnesota
|
|
4
|
|
|
3
|
|
Missouri
|
|
3
|
|
|
2
|
|
Nebraska
|
|
1
|
|
|
1
|
|
Nevada
|
|
1
|
|
|
1
|
|
New Jersey
|
|
7
|
|
|
6
|
|
New Mexico
|
|
1
|
|
|
1
|
|
New York
|
|
14
|
|
|
9
|
|
North Carolina
|
|
5
|
|
|
4
|
|
Ohio
|
|
5
|
|
|
5
|
|
Oklahoma
|
|
1
|
|
|
—
|
|
Oregon
|
|
2
|
|
|
2
|
|
Pennsylvania
|
|
6
|
|
|
6
|
|
Rhode Island
|
|
1
|
|
|
—
|
|
South Carolina
|
|
1
|
|
|
1
|
|
Tennessee
|
|
3
|
|
|
3
|
|
Texas
|
|
14
|
|
|
10
|
|
Utah
|
|
2
|
|
|
1
|
|
Vermont
|
|
1
|
|
|
1
|
|
Virginia
|
|
3
|
|
|
3
|
|
Washington
|
|
6
|
|
|
3
|
|
Wisconsin
|
|
2
|
|
|
2
|
|
Total United States
|
|
166
|
|
|
135
|
|
Canada
|
|
|
|
|
||
Alberta
|
|
12
|
|
|
12
|
|
British Columbia
|
|
11
|
|
|
12
|
|
Manitoba
|
|
2
|
|
|
2
|
|
Nova Scotia
|
|
1
|
|
|
1
|
|
Ontario
|
|
20
|
|
|
18
|
|
Quebec
|
|
5
|
|
|
4
|
|
Saskatchewan
|
|
2
|
|
|
2
|
|
Total Canada
|
|
53
|
|
|
51
|
|
Australia
|
|
|
|
|
||
Australian Capital Territory
|
|
1
|
|
|
1
|
|
New South Wales
|
|
7
|
|
|
7
|
|
Queensland
|
|
3
|
|
|
3
|
|
South Australia
|
|
1
|
|
|
1
|
|
Tasmania
|
|
1
|
|
|
1
|
|
Victoria
|
|
8
|
|
|
7
|
|
Western Australia
|
|
4
|
|
|
3
|
|
Total Australia
|
|
25
|
|
|
23
|
|
New Zealand
|
|
3
|
|
|
2
|
|
Total
|
|
247
|
|
|
211
|
|
•
|
identify suitable store locations, the availability of which is outside of our control;
|
•
|
negotiate acceptable lease terms, including desired tenant improvement allowances;
|
•
|
hire, train and retain store personnel and field management;
|
•
|
immerse new store personnel and field management into our corporate culture;
|
•
|
source sufficient inventory levels; and
|
•
|
successfully integrate new stores into our existing operations and information technology systems.
|
•
|
political unrest, terrorism, labor disputes and economic instability resulting in the disruption of trade from foreign countries in which our products are manufactured;
|
•
|
the imposition of new laws and regulations, including those relating to labor conditions, quality and safety standards, imports, duties, taxes and other charges on imports, as well as trade restrictions and restrictions on currency exchange or the transfer of funds;
|
•
|
reduced protection for intellectual property rights, including trademark protection, in some countries, particularly China;
|
•
|
disruptions or delays in shipments; and
|
•
|
changes in local economic conditions in countries where our manufacturers, suppliers or guests are located.
|
•
|
the classification of our board of directors into three classes, with one class elected each year;
|
•
|
prohibiting cumulative voting in the election of directors;
|
•
|
the ability of our board of directors to issue preferred stock without stockholder approval;
|
•
|
the ability to remove a director only for cause and only with the vote of the holders of at least 66
2
/
3
% of our voting stock;
|
•
|
a special meeting of stockholders may only be called by our chairman or Chief Executive Officer, or upon a resolution adopted by an affirmative vote of a majority of the board of directors, and not by our stockholders;
|
•
|
prohibiting stockholder action by written consent; and
|
•
|
our stockholders must comply with advance notice procedures in order to nominate candidates for election to our board of directors or to place stockholder proposals on the agenda for consideration at any meeting of our stockholders.
|
Period(1)
|
|
Total Number
of Shares
Purchased(2)
|
|
Average
Price Paid
per Share
|
|
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs(3)
|
|
Maximum Number
of Shares that
May Yet Be
Purchased Under
the Plans
or Programs(2,3)
|
|||||
August 5, 2013 - September 1, 2013
|
|
8,541
|
|
|
$
|
70.91
|
|
|
8,541
|
|
|
5,468,816
|
|
September 2, 2013 - October 6, 2013
|
|
7,127
|
|
|
69.95
|
|
|
7,127
|
|
|
5,461,689
|
|
|
October 7, 2013 - November 3, 2013
|
|
6,914
|
|
|
73.80
|
|
|
6,914
|
|
|
5,454,775
|
|
|
Total
|
|
22,582
|
|
|
|
|
22,582
|
|
|
|
(1)
|
Monthly information is presented by reference to our fiscal months during our
third
quarter of fiscal
2013
.
|
(2)
|
Excluded from this disclosure are shares repurchased to settle statutory employee tax withholding related to the vesting of performance-based restricted stock unit awards.
|
(3)
|
Our Employee Share Purchase Plan (ESPP) was approved by our Board of Directors and stockholders in September 2007. All shares purchased under the ESPP are purchased on the Nasdaq Global Select Market (or such other stock exchange as we may designate from time to time). Unless our Board of Directors terminates the ESPP earlier, the ESPP will continue until all shares authorized for purchase under the ESPP have been purchased. The maximum number of shares authorized to be purchased under the ESPP is 6,000,000.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit
No.
|
|
Exhibit Title
|
|
Filed
Herewith
|
|
Form
|
|
Exhibit
No.
|
|
File No.
|
|
Filing
Date
|
|
|
|
|
|
|
|
||||||
10.1*
|
|
Executive Employment Agreement, effective as of October 15, 2013 between lululemon athletica inc. and Tara Poseley
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Exchange Act Rule 13a-14(a)
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
31.2
|
|
Certification of Chief Financial Officer Pursuant to Exchange Act Rule 13a-14(a)
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
32.1
|
|
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
101**
|
|
The following financial statements from the Company’s 10-Q for the fiscal quarter ended November 3, 2013, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations and Comprehensive Income, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows (v) Notes to the Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
*
|
Denotes a compensatory plan, contract or arrangement, in which or directors or executive officers may participate.
|
**
|
Furnished herewith
|
|
|
lululemon athletica inc.
|
|
|
|
By:
|
|
/
S
/ J
OHN
E. C
URRIE
|
|
|
John E. Currie
|
|
|
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
|
Exhibit
No.
|
|
Exhibit Title
|
|
Filed
Herewith
|
|
Form
|
|
Exhibit
No.
|
|
File No.
|
|
Filing
Date
|
|
|
|
|
|
|
|
||||||
10.1*
|
|
Executive Employment Agreement, effective as of October 15, 2013 between lululemon athletica inc. and Tara Poseley
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Exchange Act Rule 13a-14(a)
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
31.2
|
|
Certification of Chief Financial Officer Pursuant to Exchange Act Rule 13a-14(a)
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
32.1
|
|
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
101**
|
|
The following financial statements from the Company’s 10-Q for the fiscal quarter ended November 3, 2013, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations and Comprehensive Income, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows (v) Notes to the Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
*
|
Denotes a compensatory plan, contract or arrangement, in which or directors or executive officers may participate.
|
**
|
Furnished herewith
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Dr. Vandebroek has served as founder and owner of Strategic Vision Ventures, LLC, a technology consulting firm, since 2021. Previously, Dr. Vandebroek was the inaugural visiting scholar at the Massachusetts Institute of Technology School of Engineering for the 2019-2020 academic year; Vice President, Emerging Technology Partnerships for IBM from 2018 to 2019; and Chief Operating Officer - IBM Research from 2017 to 2018. Prior to joining IBM, she was an executive with Xerox Corporation, where her roles included serving as Chief Technology Officer and Corporate Vice President of Xerox Corporation, President of the Xerox Innovation Group, and Chief Engineer. She was also responsible for overseeing Xerox’s global research centers, including the Palo Alto Research Center, or PARC Inc. Dr. Vandebroek currently serves on the boards of IDEXX Laboratories, Inc. and Wolters Kluwer N. V., both of which are publicly traded, as well as Inari Agriculture, Inc., a privately held biotechnology company, and formerly served on the board of Analogic Corporation. In 2021, Dr. Vandebroek was appointed an honorary Professor at KU Leuven, Belgium. Dr. Vandebroek is the Chair of the Advisory Committee of the Flanders AI Research Program and a Fellow of the Institute of Electrical & Electronics Engineers. Dr. Vandebroek holds a bachelor’s degree and a master’s degree in electro-mechanical engineering from KU Leuven, Leuven, Belgium, and a doctoral degree in electrical engineering from Cornell University. | |||
Mr. Chapin retired from Bank of America Merrill Lynch in 2016 as Executive Vice Chairman of Global Corporate & Investment Banking, after more than thirty years in investment banking. As Executive Vice Chairman from 2010 to 2016 he was responsible for managing relationships with some of the firm’s largest clients. Mr. Chapin has worked on a broad range of financings and strategic advisory assignments totaling more than $500 billion and has been named Investment Banker of the Year by Investment Dealers’ Digest . Mr. Chapin was named Vice Chairman of Merrill Lynch & Co., Inc. in 2003 and was a member of the firm’s executive Operating Committee. Mr. Chapin served in a number of other senior leadership positions while at Bank of America Merrill Lynch, including having responsibility for the Global Investment Banking division and managing many of the firm’s global corporate relationships. Mr. Chapin has served since 2019 as a Senior Advisor to Rockefeller Capital Management, a leading independent, privately owned financial services firm. He is also a member of the board of directors of O-I Glass, Inc. and PHINIA, Inc., both of which are publicly traded, and until 2023 was a director of CIRCOR International, Inc. Additionally, he serves as a trustee emeritus of Lafayette College and as a director emeritus of New York’s Roundabout Theatre Company. Mr. Chapin holds a Bachelor of Arts degree from Lafayette College and a Master of Business Administration degree from The Wharton School at the University of Pennsylvania. | |||
Dr. Singh was elected President and Chief Executive Officer of Revvity effective December 30, 2019, and appointed to our board of directors in 2019. Previously, Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined Revvity as the President of our Diagnostics business in 2014. He was elected Senior Vice President in 2016 and Executive Vice President in 2018. Prior to joining Revvity, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently at Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. | |||
Dr. Barrett joined Atlas Venture, an early-stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group, where he has been involved in the creation of several therapeutic and drug discovery platform companies. Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics which in 2001 announced the first successful sequencing of the human genome. Prior to that, Dr. Barrett held several senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development, where he operated several businesses and helped to greatly expand its life sciences portfolio through a series of licensing agreements, partnerships and acquisitions. He currently serves as the Chairman of Synlogic, Inc., which is publicly traded, and is a board member of privately held Obsidian Therapeutics, Inc. Dr. Barrett is also an executive fellow at the Harvard Business School and is the chair of the key advisory board of the Blavatnik Fellowship program. Dr. Barrett previously served on the board of Larimar Therapeutics, Inc., a publicly traded company, until 2023. In addition, Dr. Barrett is a board member of Nucleate, a student run non-profit organization representing the global community of bio-innovators. Dr. Barrett received his Bachelor of Science degree in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his doctoral degree in analytical chemistry from Northeastern University. | |||
Ms. Witz has served as the President of PWH Advisors, a consultancy firm advising healthcare and investment companies, since founding the firm in 2016. Previously, Ms. Witz served as a Member of the Executive Committee for Sanofi, S. A., most recently as Executive Vice President, Global Diabetes & Cardiovascular, and previously as Executive Vice President, Global Pharma and Consumer Healthcare divisions. Before joining Sanofi, Ms. Witz served as President and Chief Executive Officer of GE’s pharmaceutical diagnostics, a $2 billion integrated pharmaceutical business that encompassed research and development through commercialization. Previously Ms. Witz served with GE Healthcare, where she held positions of increasing responsibility in Europe and the United States. Before joining GE Healthcare, Ms. Witz was previously employed with Becton Dickinson Pharmaceutical Systems. Ms. Witz currently serves on the boards of publicly traded companies Fresenius Medical Care AG and Regulus Therapeutics, Inc., as well as several privately held companies. Ms. Witz formerly served on the boards of publicly traded Horizon Therapeutics plc until 2023, Savencia SA until 2018, and Tesaro, Inc. until 2019. Ms. Witz received her Master of Business Administration degree from INSEAD, Fontainebleau, France and her Master of Science degree in biochemistry from the Institut National des Sciences Appliquées, Lyon, France. She was also a doctoral student in molecular biology at the Centre National de la Recherche Scientifique, Strasbourg, France. | |||
MICHELLE MCMURRY-HEATH, MD, PhD : Age 55; Principal Occupation: Founder and Chief Executive Officer, BioTechquity Clinical. Director of Revvity since 2022. Member of the compensation and benefits committee. | |||
MICHEL VOUNATSOS : Age 63; Principal Occupation: Former Chief Executive Officer of Biogen Inc. Director of Revvity since 2020. Chair of the nominating and corporate governance committee and member of the audit committee. | |||
Mr. Klobuchar joined Eikon Therapeutics in 2024, and oversees the company’s corporate infrastructure, including global supply chain management and product manufacturing. Mr. Klobuchar is a member of Eikon’s Executive Committee and manages key executives across a variety of functional areas and business operations. Prior to joining Eikon, Mr. Klobuchar had been associated with Merck & Co., Inc., a premier research-intensive global biopharmaceutical company, for over 25 years, most recently serving from 2021 to 2024 as Executive Vice President and Chief Strategy Officer, and from 2019 to 2021 as Senior Vice President, CFO and Head of Portfolio and Alliance Management for Merck Research Laboratories. Prior to that, Mr. Klobuchar held a variety of positions of increasing responsibility in Merck’s research, manufacturing, commercial planning, finance and strategy organizations, including leading key elements related to the integration of Merck Research Laboratories with Schering-Plough R&D following the merger of the two companies. Mr. Klobuchar received his Master of Business Administration degree from Villanova University, a Master of Science degree in chemical engineering from Rutgers University and a Bachelor of Science degree from Purdue University. | |||
FRANK WITNEY, PhD : Age 71; Principal Occupation: Former Chief Executive Officer, Affymetrix, Inc., a leading provider of microarray technology; Director of Revvity since 2016. Member of the compensation and benefits and nominating and corporate governance committees. | |||
Mr. Michas is the founder and has been Managing Partner of Juniper Investment Company, LLC since 2008. Juniper is also a Principal of Aetolian Investors, LLC, a registered commodity pool operator. Mr. Michas received a Bachelor of Arts degree from Harvard College and a Master of Business Administration degree from Harvard Business School. Mr. Michas is the Non-Executive Chairman of the board of BorgWarner Inc. and a board member of AstroNova, Inc., both of which are publicly traded. Mr. Michas is also a director of funds managed by Atlantic Investment Management, Inc., a privately held investment company, as well as a board member of privately held Theragenics Corporation. Mr. Michas also served as the Non-Executive Chairman of the board of Lincoln Educational Services Corporation until 2015, and as a director of Allied Motion Technologies, Inc. until July 2017. |
Name and Principal Position |
Year |
Salary
($) |
Bonus
($) |
Stock
Awards ($) |
Option
Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
All Other
Compensation ($) |
Total ($) | ||||||||||||||||||||||||||||||||
Prahlad R. Singh Chief Executive Officer |
2024 | $ | 1,100,000 | — | $ | 4,125,038 | $ | 4,116,298 | $ | 2,530,440 | $ | 54,839 | $ | 11,926,615 | ||||||||||||||||||||||||||
2023 | $ | 1,086,539 | — | $ | 5,775,022 | $ | 1,921,023 | $ | 315,563 | $ | 32,477 | $ | 9,130,624 | |||||||||||||||||||||||||||
2022 | $ | 1,050,000 | — | $ | 5,512,467 | $ | 1,836,460 | $ | 2,152,763 | $ | 25,309 | $ | 10,576,998 | |||||||||||||||||||||||||||
Maxwell Krakowiak Senior Vice President and Chief Financial Officer
|
2024 | $ | 507,692 | — | $ | 1,050,013 | $ | 1,047,775 | $ | 615,038 | $ | 25,168 | $ | 3,245,686 | ||||||||||||||||||||||||||
2023 | $ | 500,000 | — | $ | 1,468,779 | $ | 654,938 | $ | 111,563 | $ | 19,548 | $ | 2,754,828 | |||||||||||||||||||||||||||
2022 | $ | 365,124 | $ | 50,000 | $ | 324,899 | $ | 324,955 | $ | 383,210 | $ | 16,250 | $ | 1,464,439 | ||||||||||||||||||||||||||
Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary
|
2024 | $ | 550,000 | — | $ | 1,031,208 | $ | 1,029,084 | $ | 732,188 | $ | 39,086 | $ | 3,381,566 | ||||||||||||||||||||||||||
2023 | $ | 547,308 | — | $ | 1,443,756 | $ | 480,244 | $ | 122,719 | $ | 50,715 | $ | 2,644,742 | |||||||||||||||||||||||||||
2022 | $ | 538,115 | — | $ | 1,214,971 | $ | 404,768 | $ | 703,688 | $ | 44,015 | $ | 2,905,558 | |||||||||||||||||||||||||||
Miriame Victor Senior Vice President and Chief Commercial Officer
|
2024 | $ | 467,692 | — | $ | 727,508 | $ | 725,981 | $ | 530,299 | $ | 26,166 | $ | 2,477,646 | ||||||||||||||||||||||||||
2023 | $ | 447,077 | — | $ | 862,557 | $ | 286,903 | $ | 83,870 | $ | 24,450 | $ | 1,704,856 | |||||||||||||||||||||||||||
Tajinder S. Vohra Senior Vice President Global Operations
|
2024 | $ | 475,000 | — | $ | 653,115 | $ | 651,738 | $ | 504,189 | $ | 25,311 | $ | 2,309,353 | ||||||||||||||||||||||||||
2023 | $ | 470,962 | — | $ | 890,613 | $ | 296,287 | $ | 79,943 | $ | 23,170 | $ | 1,760,975 | |||||||||||||||||||||||||||
2022 | $ | 451,923 | — | $ | 689,905 | $ | 229,892 | $ | 452,695 | $ | 22,623 | $ | 1,847,038 |
Customers
Customer name | Ticker |
---|---|
Abercrombie & Fitch Co. | ANF |
Macy's, Inc. | M |
The Gap, Inc. | GPS |
Kohl's Corporation | KSS |
Nordstrom, Inc. | JWN |
Ross Stores, Inc. | ROST |
The TJX Companies, Inc. | TJX |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Singh Prahlad R. | - | 90,195 | 37,163 |
Singh Prahlad R. | - | 83,016 | 25,088 |
MICHAS ALEXIS P | - | 58,203 | 500 |
Goldberg Joel S | - | 33,400 | 63,709 |
Goldberg Joel S | - | 27,319 | 63,709 |
Vohra Tajinder S | - | 22,625 | 0 |
Witney Frank | - | 18,662 | 0 |
Witz Pascale | - | 13,705 | 0 |
Tereau Daniel R | - | 11,611 | 0 |
Krakowiak Maxwell | - | 7,202 | 0 |
Victor Miriame | - | 6,960 | 0 |
Gonzales Anita | - | 4,522 | 0 |
Okun Andrew | - | 4,356 | 8 |
Gonzales Anita | - | 3,859 | 0 |
McMurry-Heath Michelle | - | 3,021 | 0 |
Vandebroek Sophie V. | - | 481 | 0 |